|
ABOUT COMPANY
Dyne Therapeutics, Inc., a muscle disease company, is a biotechnology company focused on advancing therapeutics for genetically-derived muscle diseases in the United States. The company is headquartered in Waltham, Massachusetts.
|
EARNINGS
Gross Profit (TTM): 0
Market Capitalization: 612674000
Operating Margin (TTM): 0
PE Ratio: None
PEG Ratio: 0.19
Profit Margin: 0
Revenue Per Share (TTM): 0
Revenue (TTM): 0
Quarterly Earnings Growth YOY: 0
Quarterly Revenue Growth YOY: 0
Trailing PE: -
|
DIVIDENDS
Diluted EPS (TTM): -2.557
Dividend Date: None
Dividend Per Share: None
Dividend Yield: 0%
EBITDA: 753000000
ExDividend Date: None
Forward Annual Dividend Rate:
Forward Annual Dividend Yield:
|